Used in biomedical research to measure levels of rat type I procollagen C-terminal propeptide in biological samples, this ELISA kit serves as a sensitive tool for assessing bone formation and collagen synthesis. It is widely applied in studies related to bone metabolism, osteoporosis, and connective tissue disorders in preclinical animal models. Researchers use it to monitor the efficacy of therapeutic agents targeting bone growth or fibrosis. The assay enables quantification of CⅠCP in serum or plasma, providing insight into type I collagen turnover, which is critical in evaluating skeletal development, healing processes, and disease progression in rodent-based research.